Activation of T lymphocytes often leads to cellular activation, produc
tion of cytokines, entry into cell cycle, and expression of Fas (CD95)
and Fas ligand (FasL), Although it is well established that the inter
action of Fas and Fast results in apoptosis, mechanisms for regulated
expression of Fas and Fast are unclear. Our previous work with antisen
se oligodeoxynucleotides suggested that the protooncogene c-myc is obl
igatory for activation-induced apoptosis, To study the relationship be
tween myc and the Fas/FasL expression, we employed the antisense metho
d and a newly identified fungal metabolite, FR901228, which has been s
hown to specifically inhibit expression of c-myc in fibroblasts, We fo
und that FR901228 could effectively block activation-induced apoptosis
in T cell hybridomas and this was correlated with its specific inhibi
tion of c-myc expression, Both FR901228 and antisense oligodeoxynucleo
tide to c-myc had similar effect in inhibiting Fast expression. These
treatments did not affect activation-induced production of IL-2, nor t
he expression of Fas, In addition, FR901228 inhibited the expression o
f Fast in 3T3 fibroblasts, but not these transfected with c-myc, suppo
rting a specific role of c-myc in this process. Thus, c-Myc plays a fu
ndamental role in the regulation of the expression of Fast, but not Fa
s and IL-2, Our data further defined the requirement of c-Myc in activ
ation-induced apoptosis in T cells.